543 related articles for article (PubMed ID: 17071739)
1. Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome.
Shaw EA; Colville D; Wang YY; Zhang KW; Dagher H; Fassett R; Guymer R; Savige J
Nephrol Dial Transplant; 2007 Jan; 22(1):104-8. PubMed ID: 17071739
[TBL] [Abstract][Full Text] [Related]
2. The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.
Colville D; Wang YY; Tan R; Savige J
Br J Ophthalmol; 2009 Mar; 93(3):383-6. PubMed ID: 19019929
[TBL] [Abstract][Full Text] [Related]
3. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
[TBL] [Abstract][Full Text] [Related]
4. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
5. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
6. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
8. Collagen type IV nephropathy: genetic heterogeneity examinations in affected Hungarian families.
Endreffy E; Ondrik Z; Iványi B; Maróti Z; Bereczki C; Haszon I; Györke Z; Worum E; Németh K; Rikker C; Ökrös Z; Túri S
Mol Cell Probes; 2011 Feb; 25(1):28-34. PubMed ID: 20951199
[TBL] [Abstract][Full Text] [Related]
9. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and genetic features of the Alport 'syndromes'].
Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome and thin basement membrane nephropathy.
Thorner PS
Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
[TBL] [Abstract][Full Text] [Related]
12. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome.
Dagher H; Buzza M; Colville D; Jones C; Powell H; Fassett R; Wilson D; Agar J; Savige J
Am J Kidney Dis; 2001 Dec; 38(6):1217-28. PubMed ID: 11728953
[TBL] [Abstract][Full Text] [Related]
14. Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.
Dagher H; Yan Wang Y; Fassett R; Savige J
Hum Mutat; 2002 Oct; 20(4):321-2. PubMed ID: 12325029
[TBL] [Abstract][Full Text] [Related]
15. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
16. The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms.
Liu J; Colville D; Wang YY; Baird PN; Guymer RH; Savige J
Br J Ophthalmol; 2009 Mar; 93(3):379-82. PubMed ID: 19019939
[TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic features in autosomal recessive and X-linked Alport syndrome.
Wang Y; Sivakumar V; Mohammad M; Colville D; Storey H; Flinter F; Dagher H; Savige J
Pediatr Nephrol; 2014 Mar; 29(3):391-6. PubMed ID: 24178893
[TBL] [Abstract][Full Text] [Related]
19. The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.
Zhang KW; Colville D; Tan R; Jones C; Alexander SI; Fletcher J; Savige J
Pediatr Nephrol; 2008 Aug; 23(8):1245-50. PubMed ID: 18343956
[TBL] [Abstract][Full Text] [Related]
20. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
